Clinical Trials Logo
  1. Home
  2. Malignant Brain Tumor
  3. NCT05669326

Evaluation of the Contribution of NODDI Protocol Tractography in Brain Tumor Surgery — NODDI-TRACT  

Malignant Brain Tumor Clinical Trial

Official title:
Evaluation of the Contribution of NODDI Protocol Tractography in Brain Tumor Surgery

Clinical Trial Summary

The objective of this study is to evaluate to what extent the capacity of the NODDI model can allow, in case of Malignant brain tumor patients with vasogenic edema, the elaboration of a reliable cerebral functional mapping in accordance with the data of direct electrical stimulation (DES) which is today the reference tool. the patient's participation in this study implies an additional visit during which an MRI examination without injection of contrast medium will be performed, lasting approximately 40 minutes (including installation and de-installation).

Clinical Trial Description

This is a single-center, prospective, open-label study of neurosurgical patients. Compared to their usual management, the participation of the patient in this study implies an additional visit during which an MRI examination without injection of contrast product will be performed, lasting approximately 40 minutes (including installation and de-installation). The operative time, surgical procedures and postoperative follow-up are not modified in this study ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT05669326
Study type Interventional
Source GCS Ramsay Santé pour l'Enseignement et la Recherche
Contact
Status Not yet recruiting
Phase N/A
Start date February 1, 2023
Completion date February 1, 2024
View Details
See also
  Status Clinical Trial Phase
Completed NCT04109209 - Psychological Intervention For Brain Tumor Caregivers N/A
Completed NCT02798406 - Combination Adenovirus + Pembrolizumab to Trigger Immune Virus Effects Phase 2
Completed NCT04351035 - National Wide Cross-sectional Study in Paediatric Central Nervous System Tumours in China -- the CNOG-MC001 Registry
Completed NCT02502708 - Study of the IDO Pathway Inhibitor, Indoximod, and Temozolomide for Pediatric Patients With Progressive Primary Malignant Brain Tumors Phase 1
Recruiting NCT05976490 - NeuroPathways Intervention for Brain Tumor Patients N/A
Terminated NCT02128373 - A Computer-Based Intervention for Distance Caregivers of Parents With Advanced Cancer N/A
Terminated NCT02885324 - Pilot Study of Cabozantinib for Recurrent or Progressive Central Nervous System Tumors in Children Phase 2
Not yet recruiting NCT06099743 - ASCENT Intervention for Brain Tumor Patients N/A
Terminated NCT02880111 - Rates DMBT1 ( Glycoprotein) in Sputum of CF Patients With Pseudomonas Aeruginosa
Completed NCT02052648 - Study of IDO Inhibitor and Temozolomide for Adult Patients With Primary Malignant Brain Tumors Phase 1/Phase 2
Not yet recruiting NCT06098248 - cCeLL - Ex Vivo (Confocal Fluorescence Endomicroscopy) for Intraoperative Brain Tumor Diagnosis N/A
Completed NCT00418327 - Safety Study of Tarceva in Children With Refractory and Relapsed Malignant Brain Tumors and Newly Diagnosed Brain Stem Glioma Phase 1
Recruiting NCT05293197 - Safety Study of the Repeated Opening of the Blood-brain Barrier With the SonoCloud® Device to Treat Malignant Brain Tumors in Pediatric Patients Phase 1
Recruiting NCT06092125 - Clinical Applicantion of Multi-Tracer PET/MR Imaging in Neurological Disorders/Disease
Suspended NCT05169944 - Magrolimab in Children and Adults With Recurrent or Progressive Malignant Brain Tumors Phase 1